StreetAlpha.app
Home › Stocks › OGN

Organon & Co. (OGN)

Healthcare
$13.90
▼ −0.04%
LAST CLOSE · NOV 17

Organon makes women's health drugs, biosimilars and established brands sold to wholesalers, hospitals and healthcare providers. It last closed at $13.90 on Nov 17, down 0.04% on the day. OGN reports earnings on Thu, Feb 11, 2027. In the past 30 days there were 1 dark pool print totaling $731K, the largest $731K.

AI Auto Pilots
Is OGN in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$6.1B
−3.2% vs a year ago
Net income
$213.0M
−57.5% vs a year ago
EPS (diluted)
$0.78
−59.2% vs a year ago
Free cash flow
$675.0M
11.1% margin
Valuation
Market cap
$3.7B
262.6M shares
P/E
17.8
Price over 12 month EPS
Price to sales
0.6
Market cap over revenue
Dividend yield
0.58%
$0.08 a share over 12 months
Balance sheet
Cash & equivalents
$1.5B
At Sep 30
Debt
$8.6B
At Sep 30
Shareholder equity
$1.2B
Shares outstanding
262.6M
At Oct 23
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $6.3B$6.3BFY2021FY2022: $6.2B$6.2BFY2022FY2023: $6.3B$6.3BFY2023FY2024: $6.4B$6.4BFY2024FY2025: $6.2B$6.2BFY2025

From OGN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.

Next report
Feb 11
2027 · Time not announced
Consensus EPS forecast
$0.92
$1.54B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
—
No ratings in 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
No firm has rated OGN in the past 90 days.
Average 12-month target
No price targets on OGN in the past 90 days.
Latest rating changes
BNP ParibasDowngrade
Apr 29Hold$14
Piper SandlerUpgrade
Apr 28Hold$14
DateFirmActionRatingPrice target
Apr 29BNP ParibasDowngradeHold$14
Apr 28Piper SandlerUpgradeHold$14
Loading…

Technical Analysis

OGN · as of the Nov 17 close · updated after every close
Moving sideways, nearing overbought

The stock is 1% above its 20 day and 1% above its 50 day average. It is 15% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 67), near overbought. The nearest support is the Pivot S1 at $13.89, and the nearest resistance the Pivot R1 at $13.91.

Short trendNeutral
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityLow, 0.3%/day
Key levels
$13.9152 week high+0.1%
$13.91Pivot R1+0.1%
$13.90Pivot+0.0%
$13.90Last close
$13.89Pivot S1−0.1%
$13.8320 day average−0.5%
$13.78Swing low (Nov 6)−0.9%
$13.7650 day average−1.0%
$13.69100 day average−1.5%
$11.81200 day average−15.0%
$5.6952 week low−59.1%
Indicators
RSI (14)67.01Strong, overbought above 70Neutral
MACD0.04Above its signal lineBullish
Stochastic96.7Near the top of its rangeOverbought
ADX (14)33.8Trending up
Williams %R-6.7Oversold below −80, overbought above −20Overbought
CCI (20)106.8Oversold below −100, overbought above 100Overbought
Rate of change+0.4%Change over 10 sessionsBullish
ATR (14)$0.04Typical daily range, 0.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for OGN

What happened before

See how OGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow OGN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How OGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in OGN in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
1
Notional
$731K
Largest print
$731K
Loading…

OGN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼200 buying vs 261 selling
  • ▲Held by funds +2.8 pts
  • ▼Funds holding -29
  • ▲Superinvestors: 2 added, 1 cut
  • ▼Put/call 1.63 to 3.51
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding607636−4.6%
In funds' top 10660.0%
Held by funds86.1%83.3%+2.8 pts
New / increased52 / 148111 / 119−13.0%
Reduced / sold out188 / 73193 / 92−8.4%
Put/call ratio3.511.63+115.8%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See OGN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OGN is in one of them and how their past OGN trades turned out.

OGN in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered OGN in an article yet. Here's the latest on the wider market.

OGN Congress Trades

All congress trades →
Trades, 12 months
6
Buys
1
17%
Sells
5
83%
People
3
Last filed Sep 22
Who traded OGN · since 2021
Latest 5 filings of 37
$15K – $50KTraded Jul 29, 2026Filed Sep 22, 2026
$1K – $15KTraded Aug 5, 2026Filed Aug 10, 2026
$1K – $15KTraded Aug 5, 2026Filed Aug 10, 2026
$1K – $15KTraded May 15, 2026Filed Jul 1, 2026
$15K – $50KTraded Mar 4, 2026Filed May 14, 2026
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$15K – $50KJul 29, 2026Sep 22, 202655 d
Kevin HernR · OKSell$1K – $15KAug 5, 2026Aug 10, 20265 d
Kevin HernR · OKSell$1K – $15KAug 5, 2026Aug 10, 20265 d
Donald J TrumpExecutive branchSell$1K – $15KMay 15, 2026Jul 1, 202647 d
Donald J TrumpExecutive branchBuy$15K – $50KMar 4, 2026May 14, 202671 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Organon &

Organon is a healthcare company based in Jersey City, New Jersey, that makes prescription medicines. Its women's health line includes contraceptive products such as an implant and a vaginal ring, along with fertility treatments. It also sells biosimilars, which are versions of biologic drugs, and established brands in areas such as cardiovascular, respiratory and dermatology care. Customers include drug wholesalers, retailers, hospitals, government agencies and managed healthcare providers, and products are sold in more than 140 countries.

Headquarters
Jersey City, NJ
Founded
1923